2025
Preliminary Evidence for Perturbation‐Based tACS‐EEG Biomarkers of Gamma Activity in Alzheimer's Disease
Palmisano A, Pezanko L, Cappon D, Tatti E, Macone J, Koch G, Smeralda C, Romanella S, Ruffini G, Rivolta D, Press D, Pascual‐Leone A, El‐Fakhri G, Santarnecchi E. Preliminary Evidence for Perturbation‐Based tACS‐EEG Biomarkers of Gamma Activity in Alzheimer's Disease. International Journal Of Geriatric Psychiatry 2025, 40: e70025. PMID: 39799469, DOI: 10.1002/gps.70025.Peer-Reviewed Original ResearchConceptsPeripheral neuroinflammationIdentification of novel biomarkersResponse to TACPatient's clinical phenotypeSpectral powerGABAergic dysfunctionNo significant correlationPrognostic valueInhibitory circuitryClinical severityClinical phenotypeAnimal modelsCognitive statusNeuroinflammatory markersAlzheimer's diseaseHuman patientsNeuroinflammatory biomarkersNovel biomarkersPatientsDisease severityTherapeutic targetGamma activityBiomarkersMild to moderate dementiaSignificant correlation
2019
Quantification of PET Myocardial Blood Flow
Pelletier-Galarneau M, Martineau P, El Fakhri G. Quantification of PET Myocardial Blood Flow. Current Cardiology Reports 2019, 21: 11. PMID: 30815744, DOI: 10.1007/s11886-019-1096-x.Peer-Reviewed Original ResearchConceptsPositron emission tomographyMyocardial blood flowMyocardial flow reserveMicrovascular dysfunctionEvaluation of cardiac allograft vasculopathyAssessment of coronary microvascular dysfunctionFlow reserveHyperemic myocardial blood flowFlow quantificationCardiac allograft vasculopathyMarkers of disease severityCoronary microvascular dysfunctionImprove risk stratificationQuantification of myocardial blood flowFractional flow reserveMyocardial blood flow quantificationAllograft vasculopathyPrognostic valueRisk stratificationEpicardial diseaseAcademic centersReviewThe aimClinical aspectsEmission tomographyBlood flow
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply